(WEX) Wex - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US96208T1043

Fleet Cards, Corporate Payments, Benefits Software

Data Processing & Outsourced Services
Market Cap in USD: 5,272m

IPO / Inception: 2005-02-16
12m vs SPY: -24.2%

EPS (Earnings per Share)

EPS CAGR: -44.56%
EPS Trend: -32.8%

Last SUE: -4.00
Qual. Beats: 0

Revenue

Rev. CAGR: 9.19%
Rev. Trend: 79.6%

Last SUE: 0.87
Qual. Beats: 1

Dividends

Currently no dividends paid

Risk via 5d forecast
Volatility	27.9%
Value at Risk 5%th	41.5%
Relative Tail Risk	-9.67%

Reward TTM
Sharpe Ratio	0.00
Alpha	-33.85
CAGR/Max DD	-0.06

Character TTM
Hurst Exponent	0.352
Beta	1.429
Beta Downside	1.564

Drawdowns 3y
Max DD	53.15%
Mean DD	20.47%
Median DD	21.46%

Description: WEX Wex January 09, 2026

WEX Inc. (NYSE: WEX) runs a diversified commerce platform that spans three primary segments: Mobility, Corporate Payments, and Benefits Solutions. The Mobility segment delivers fleet-vehicle payment processing, account-management services, and analytics to commercial fleets and government agencies, leveraging both direct sales and co-branded/private-label partnerships. Corporate Payments offers embedded payment capabilities, accounts-payable automation, and spend-management tools to customers in travel, fintech, insurance, consumer-bill-pay, and media verticals. Benefits Solutions provides a SaaS platform for consumer-directed health benefits-including HSAs, HSAs, and COBRA administration-served through third-party administrators, payroll providers, and health plans.

Based on the FY 2023 earnings release, WEX generated $2.0 billion in revenue, with the Mobility segment contributing roughly 55 % and posting a 7 % year-over-year growth rate, driven by increasing demand for electric-vehicle fleet financing and higher transaction volumes. The Corporate Payments unit grew 9 % YoY, reflecting broader corporate spend-management trends and the acceleration of digital invoicing post-COVID-19. Benefits Solutions, while smaller (≈ 15 % of total revenue), posted a 12 % increase, underscoring the continued shift toward consumer-direct health accounts as employers seek cost-containment. Key economic drivers include corporate capital-expenditure cycles, regulatory changes in healthcare benefits (e.g., HSA contribution limits), and the macro-trend toward embedded finance in non-financial industries.

For a deeper, data-driven look at how these trends translate into valuation metrics, you might explore the analytics available on ValueRay.

Piotroski VR‑10 (Strict, 0-10) 4.0

Net Income (283.8m TTM) > 0 and > 6% of Revenue (6% = 157.5m TTM)

FCFTA 0.04 (>2.0%) and ΔFCFTA 1.23pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 17.61% (prev 14.74%; Δ 2.87pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.06 (>3.0%) and CFO 798.0m > Net Income 283.8m (YES >=105%, WARN >=100%)

Net Debt (4.21b) to EBITDA (916.3m) ratio: 4.60 <= 3.0 (WARN <= 3.5)

Current Ratio 1.05 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (34.8m) change vs 12m ago -12.56% (target <= -2.0% for YES)

Gross Margin 59.06% (prev 60.98%; Δ -1.92pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 18.49% (prev 19.02%; Δ -0.53pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 2.63 (EBITDA TTM 916.3m / Interest Expense TTM 239.2m) >= 6 (WARN >= 3)

Altman Z'' 1.19

(A) 0.03 = (Total Current Assets 9.72b - Total Current Liabilities 9.25b) / Total Assets 14.43b

(B) 0.16 = Retained Earnings (Balance) 2.29b / Total Assets 14.43b

(D) 0.16 = Book Value of Equity 2.15b / Total Liabilities 13.31b

Total Rating: 1.19 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 61.17

1. Piotroski 4.0pt

2. FCF Yield 6.78%

3. FCF Margin 24.48%

4. Debt/Equity 4.49

5. Debt/Ebitda 4.60

6. ROIC - WACC (= 0.84)%

7. RoE 25.82%

8. Rev. Trend 79.61%

9. EPS Trend -32.80%

What is the price of WEX shares?

As of January 13, 2026, the stock is trading at USD 160.83 with a total of 549,329 shares traded.
Over the past week, the price has changed by +5.67%, over one month by +4.58%, over three months by +6.79% and over the past year by -8.24%.

Is WEX a buy, sell or hold?

Wex has received a consensus analysts rating of 3.31. Therefor, it is recommend to hold WEX.

Strong Buy: 2
Buy: 1
Hold: 13
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the WEX price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	176.9	10%
Analysts Target Price	176.9	10%
ValueRay Target Price	160.9	0%

WEX Fundamental Data Overview January 09, 2026

P/E Trailing = 19.9922
P/E Forward = 8.7184
P/S = 2.0086
P/B = 4.7134
P/EG = 1.4537
Beta = 0.991
Revenue TTM = 2.62b USD
EBIT TTM = 630.0m USD
EBITDA TTM = 916.3m USD
Long Term Debt = 3.72b USD (from longTermDebt, last quarter)
Short Term Debt = 1.31b USD (from shortTermDebt, last quarter)
Debt = 5.03b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.21b USD (from netDebt column, last quarter)
Enterprise Value = 9.48b USD (5.27b + Debt 5.03b - CCE 812.9m)
Interest Coverage Ratio = 2.63 (Ebit TTM 630.0m / Interest Expense TTM 239.2m)
EV/FCF = 14.76x (Enterprise Value 9.48b / FCF TTM 642.6m)
FCF Yield = 6.78% (FCF TTM 642.6m / Enterprise Value 9.48b)
FCF Margin = 24.48% (FCF TTM 642.6m / Revenue TTM 2.62b)
Net Margin = 10.81% (Net Income TTM 283.8m / Revenue TTM 2.62b)
Gross Margin = 59.06% ((Revenue TTM 2.62b - Cost of Revenue TTM 1.07b) / Revenue TTM)
Gross Margin QoQ = 60.35% (prev 58.64%)
Tobins Q-Ratio = 0.66 (Enterprise Value 9.48b / Total Assets 14.43b)
Interest Expense / Debt = 1.27% (Interest Expense 63.8m / Debt 5.03b)
Taxrate = 31.10% (36.2m / 116.4m)
NOPAT = 434.1m (EBIT 630.0m * (1 - 31.10%))
Current Ratio = 1.05 (Total Current Assets 9.72b / Total Current Liabilities 9.25b)
Debt / Equity = 4.49 (Debt 5.03b / totalStockholderEquity, last quarter 1.12b)
Debt / EBITDA = 4.60 (Net Debt 4.21b / EBITDA 916.3m)
Debt / FCF = 6.56 (Net Debt 4.21b / FCF TTM 642.6m)
Total Stockholder Equity = 1.10b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.00% (Net Income 283.8m / Total Assets 14.43b)
RoE = 25.82% (Net Income TTM 283.8m / Total Stockholder Equity 1.10b)
RoCE = 13.08% (EBIT 630.0m / Capital Employed (Equity 1.10b + L.T.Debt 3.72b))
RoIC = 6.99% (NOPAT 434.1m / Invested Capital 6.21b)
WACC = 6.15% (E(5.27b)/V(10.30b) * Re(11.18%) + D(5.03b)/V(10.30b) * Rd(1.27%) * (1-Tc(0.31)))
Discount Rate = 11.18% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -8.87%
[DCF Debug] Terminal Value 87.33% ; FCFF base≈565.3m ; Y1≈682.3m ; Y5≈1.11b
Fair Price DCF = 744.0 (EV 29.72b - Net Debt 4.21b = Equity 25.51b / Shares 34.3m; r=6.15% [WACC]; 5y FCF grow 22.11% → 2.90% )
EPS Correlation: -32.80 | EPS CAGR: -44.56% | SUE: -4.0 | # QB: 0
Revenue Correlation: 79.61 | Revenue CAGR: 9.19% | SUE: 0.87 | # QB: 1
EPS next Quarter (2026-03-31): EPS=4.00 | Chg30d=+0.011 | Revisions Net=+1 | Analysts=12
EPS next Year (2026-12-31): EPS=17.65 | Chg30d=-0.021 | Revisions Net=-1 | Growth EPS=+10.8% | Growth Revenue=+4.3%

Additional Sources for WEX Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle